Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort

Tamoxifen and aromatase inhibitors (AIs) are potent antitumoral agents against breast cancer. Tamoxifen increases the risk of venous thromboembolism (VTE), but the influence of AIs on the risk of VTE remains unclear. To inform clinical decisions, we evaluated associations of tamoxifen or AIs with ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Blondon, Marc, Bodmer, Alexandre, Thouvenin, Laure, Lecompte, Thomas, Righini, Marc, Fontana, Pierre, Casini, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092409/
https://www.ncbi.nlm.nih.gov/pubmed/35086148
http://dx.doi.org/10.1182/bloodadvances.2021006623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092409/
https://www.ncbi.nlm.nih.gov/pubmed/35086148
http://dx.doi.org/10.1182/bloodadvances.2021006623

Ejemplares similares